Compare WTS & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WTS | TECH |
|---|---|---|
| Founded | 1874 | 1976 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.2B | 9.5B |
| IPO Year | 1986 | 1989 |
| Metric | WTS | TECH |
|---|---|---|
| Price | $279.21 | $58.47 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 14 |
| Target Price | ★ $271.40 | $71.23 |
| AVG Volume (30 Days) | 157.4K | ★ 1.7M |
| Earning Date | 11-05-2025 | 11-05-2025 |
| Dividend Yield | ★ 0.75% | 0.55% |
| EPS Growth | ★ 16.19 | N/A |
| EPS | ★ 9.69 | 0.49 |
| Revenue | ★ $2,353,800,000.00 | $1,216,732,000.00 |
| Revenue This Year | $8.34 | $2.33 |
| Revenue Next Year | $6.11 | $7.05 |
| P/E Ratio | ★ $28.68 | $120.22 |
| Revenue Growth | ★ 4.18 | 3.85 |
| 52 Week Low | $177.59 | $46.01 |
| 52 Week High | $287.89 | $79.28 |
| Indicator | WTS | TECH |
|---|---|---|
| Relative Strength Index (RSI) | 57.41 | 41.76 |
| Support Level | $266.50 | $58.75 |
| Resistance Level | $281.60 | $61.20 |
| Average True Range (ATR) | 5.40 | 2.02 |
| MACD | 0.75 | -0.49 |
| Stochastic Oscillator | 84.20 | 2.94 |
Watts Water Technologies Inc is a U.S.-based company that provides safety, energy efficiency, and water conservation products. Its product portfolio includes residential and commercial flow control products, which are sold for plumbing and hot water applications; HVAC and gas products, including commercial boilers, water heaters, heating solutions, etc.; drainage and water reuse products, including drainage products and engineered rainwater-harvesting solutions; and water quality products, including point-of-use and point-of-entry water filtration, conditioning, and scale prevention systems. Its products are marketed through brands like Watts, Apex, Bradley, Nexa, and others. Geographically, the company derives its key revenue from the Americas, followed by Europe and the APMEA region.
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.